| Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography MS Cohen, N Arslan, F Dehdashti, GM Doherty, TC Lairmore, LM Brunt, ... Surgery 130 (6), 941-946, 2001 | 381 | 2001 |
| Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma S Ilgan, AO Karacalioglu, Y Pabuscu, GK Atac, N Arslan, E Ozturk, ... European journal of nuclear medicine and molecular imaging 31, 825-830, 2004 | 104 | 2004 |
| Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with esophageal cancer N Arslan, TR Miller, F Dehdashti, RJ Battafarano, BA Siegel Molecular Imaging & Biology 4 (4), 301-310, 2002 | 94 | 2002 |
| Cerium nitrate treatment prevents progressive tissue necrosis in the zone of stasis following burn M Eski, F Ozer, C Firat, D Alhan, N Arslan, T Senturk, S Işik Burns 38 (2), 283-289, 2012 | 74 | 2012 |
| Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery N Arslan, S Ilgan, D Yuksel, M Serdengecti, N Bulakbasi, O Ugur, ... Clinical nuclear medicine 26 (8), 683-688, 2001 | 71 | 2001 |
| Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small … N Arslan, M Tuncel, O Kuzhan, E Alagoz, B Budakoglu, A Ozet, ... Annals of nuclear medicine 25, 406-413, 2011 | 64 | 2011 |
| Post-surgical ablation of thyroid remnants with high-dose 131I in patients with differentiated thyroid carcinoma N Arslan, S Ilgan, M Serdengecti, MA Ozguven, H Bayhan, K Okuyucu, ... Nuclear medicine communications 22 (9), 1021-1027, 2001 | 62 | 2001 |
| Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis N Arslan, M Serdar, S Deveci, B Ozturk, Y Narin, S Ilgan, E Ozturk, ... Annals of nuclear medicine 14, 395-399, 2000 | 55 | 2000 |
| A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method E Öztürk, Z Yeşilova, S Ilgan, N Arslan, A Erdil, B Celasun, M Özgüven, ... European Journal of Nuclear Medicine and Molecular Imaging 30, 1457-1462, 2003 | 48 | 2003 |
| Utility of ventilation and perfusion scan in the diagnosis of young military recruits with an incidental finding of hyperlucent lung N Arslan, S Ilgan, M Ozkan, I Yuksekol, N Bulakbasi, Y Pabuscu, ... Nuclear medicine communications 22 (5), 525-530, 2001 | 47 | 2001 |
| 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis N Arslan, E Oztürk, S Ilgan, M Urhan, Ö KARAgALIOGLU, M Pekcan, ... Nuclear medicine communications 20 (4), 317-326, 1999 | 46 | 1999 |
| Unusual patterns of I-131 contamination M Ozguven, S Ilgan, N Arslan, AO Karacalioglu, D Yuksel, S Dundar Annals of nuclear medicine 18, 271-274, 2004 | 34 | 2004 |
| Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography N Arslan, B Rydzewski Clinical nuclear medicine 27 (3), 221-222, 2002 | 34 | 2002 |
| The role of FDG PET/CT in evaluation of mediastinal masses and neurogenic tumors of chest wall E Tatci, O Ozmen, Y Dadali, IU Biner, A Gokcek, F Demirag, F Incekara, ... International journal of clinical and experimental medicine 8 (7), 11146, 2015 | 33 | 2015 |
| Diagnostic accuracy of whole‐body diffusion‐weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms S Akay, M Kocaoglu, O Emer, B Battal, N Arslan Journal of medical imaging and radiation oncology 57 (3), 274-282, 2013 | 31 | 2013 |
| Abnormal 18F-FDG uptake detected with positron emission tomography in a patient with breast cancer: a case of sarcoidosis and review of the literature S Ataergin, N Arslan, MA Ozguven Case reports in medicine 2009, 2009 | 29 | 2009 |
| 18F-FDG PET/CT rarely provides additional information other than primary tumor detection in patients with pulmonary carcinoid tumors E Tatci, O Ozmen, A Gokcek, IU Biner, E Ozaydin, S Kaya, N Arslan Annals of Thoracic Medicine 9 (4), 227-231, 2014 | 28 | 2014 |
| The comparison of ultrasonographic and scintigraphic findings of early arthritis in revealing rheumatoid arthritis according to criteria of American College of Rheumatology A Ozgul, E Yasar, N Arslan, B Balaban, MA Taskaynatan, K Tezel, ... Rheumatology international 29, 765-768, 2009 | 27 | 2009 |
| Detection of widespread neurolymphomatosis with 18F-FDG PET E Öztürk, F Arpaci, M Kocaoğlu, N Arslan, N Bulakbaşi, M Özgüven European Journal of Nuclear Medicine and Molecular Imaging 33, 975-976, 2006 | 27 | 2006 |
| Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin K Okuyucu, E Alagoz, S Demirbas, S Ince, A Karakas, O Karacalioglu, ... QJ Nucl Med Mol Imaging 62 (3), 313-20, 2018 | 23 | 2018 |
Semra Incegulhane training and research hospitalVerified email at sbu.edu.tr
